Insomnia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Aged 18–60 years; (2) Body mass index (BMI) < 28 kg/m^²; (3) Willing to provide voluntary written informed consent.
Exclusion criteria
Exclusion criteria: (1) Presence of sleep disorders within the last 3 months; (2) Ectopic heartbeats >= 5 times per minute, or any form of arrhythmia with a non-1:1 P/R ratio; (3) Coagulation dysfunction; (4) Diagnosis of malignant tumors, or severe cardiovascular/cerebrovascular diseases, hepatic/renal diseases, hematologic disorders, or psychiatric illnesses; (5) Experiencing severe infection, recent surgery, or other acute stress states within the past month, or being in an acute or unstable phase of any disease; (6) Pregnancy or lactation; (7) Local skin infection at the SGB injection site; (8) Extensive skin burns, ulceration, inflammatory reactions, severe desquamation in the precordial area, or severe thoracic deformity; (9) Use of psychotropic drugs, ß-blockers, or other medications affecting HRV; (10) Any other condition considered by the investigator to be unsuitable for the trial or that may interfere with the completion of required assessments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate variability; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep quality; | — |
Countries
China
Contacts
Longgang District People's Hospital of Shenzhen